Weight-Loss Drugs Pose Risks for People Over 65, Experts Say

Could Nirvana get their own ABBA Voyage-style avatar show? Bassist Krist Novoselic had this to say...

U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report

Europe Luxury Stocks Slide as Richemont Chairman Says Inflation Is Denting Demand

The maker of Wegovy and Ozempic is now Europe's most valuable company

Novo’s Obesity Drug Arrives in UK – at a Fraction of US Prices

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Drugmaker Novo Nordisk overtakes LVMH as Europe's most valuable company

Ozempic Maker Overtakes LVMH as Biggest European Company

Ozempic Could Be The Next Target of Medicare Price Negotiations

Weight-Loss Drugs Cost Far More in US Than Other Nations

Lenovo Q1 revenue misses, hit by poor PC demand